Key result
Tricuspid valve replacement resulted in 26% hospital mortality and 37% 10-year survival, with rheumatic etiology and elevated pulmonary artery pressure unfavorably affecting long-term results.
Why the study?
Does tricuspid valve replacement improve long-term survival and functional capacity in patients with severe tricuspid valve disease?
Population
42 patients undergoing tricuspid valve replacement. Etiology: rheumatic, Ebstein's anomaly, endocarditis…
Design
Case_series
Follow-up
Up to 15 years
Authors
Loading...
High early mortality warrants cautious patient selection; Level 5 data leave open comparative trials versus repair.
Cohort (n=42)
Does tricuspid valve replacement improve long-term survival and functional capacity in patients with severe tricuspid valve disease?
Tricuspid valve replacement is associated with high early mortality (26%) and suboptimal long-term survival (37% at 10 years), with outcomes heavily dependent on etiology and pulmonary hemodynamics.
İşcan et al. (2007) conducted a cohort in Tricuspid valve disease requiring replacement (n=42). Tricuspid valve replacement was evaluated on Hospital mortality. Tricuspid valve replacement resulted in 26% hospital mortality and 37% 10-year survival, with rheumatic etiology and elevated pulmonary artery pressure unfavorably affecting long-term results.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: